US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.110
  • +0.010+0.91%
Close Sep 13 16:00 ET
  • 1.100
  • -0.010-0.90%
Post 19:58 ET
283.88MMarket Cap-3083P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Development revenue128.23M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United Kingdom (U.K.)60.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.37%